Role of pelvimetry in predicting surgical outcomes and morbidity in rectal cancer surgery: A retrospective analysis

Table 1 Distribution of demographic, surgical, pathological, clinical, and radiological characteristics of the patients included in the study

Items	Value
Age (years; n = 79)	66.32 ± 11.87
Gender (n = 79)
Male	54 (68.35)
Female	25 (31.65)
BMI (kg/m2; n = 73)	25.90 (19:44)
Tumor localization (n = 79)
Upper rectum	30 (37.97)
Middle rectum	16 (20.25)
Lower rectum	33 (41.77)
ASA score (n = 78)
I	1 (1.28)
II	30 (38.46)
III	46 (58.97)
IV	1 (1.28)
Operation type (n = 79)
Open low anterior	36 (45.57)
Laparoscopic low anterior	37 (46.84)
Miles	6 (7.59)
Operation time (min; n = 78)	237.12 ± 59.82
Blood loss cc (n = 78)	125 (50:200)
Tumor stage (n = 78)
0	5 (6.41)
1	21 (26.92)
2A	17 (21.79)
2B	3 (3.85)
3A	14 (17.95)
3B	9 (11.54)
3C	9 (11.54)
Tumor size (cm; n = 77)	3.50 (0:17)
Pelvic inlet area-CT mm2 (n = 77)	8428.65 ± 1232.66
Fecal diversion (n = 73)
Exist	48 (65.75)
None	20 (27.40)
Lymphovascular invasion (n = 74)	23 (29.90)
Average number of lymph nodes dissected (n = 77)	14.75 ± 7.99
PCI (n = 52)	10.40 ± 2
Neoadjuvant therapy (n = 79)	38 (48.10)
Adjuvant therapy (n = 74)	50 (67.60)
Follow-up period (months; n = 75)	32 (0:70)

Data are expressed as n (%), mean ± SD, and median (minimum:maximum). ASA: American Society of Anesthesiologists; CT: Computed tomography; BMI: Body mass index; PCI: Pelvic cavity index.